Basis of Presentation (Tables)

3 Months Ended

Mar. 31, 2021

Schedule of cash, cash equivalents, and restricted cash

The following table provides a reconciliation of cash, cash equivalents, and restricted cash as reported within the Unaudited Condensed Consolidated Balance Sheets to “Cash, cash equivalents, and restricted cash at end of period” as reported within the Unaudited Condensed Consolidated Statements of Cash Flows:


	Successor
In thousands	March 31, 2021		December 31, 2020
Cash and cash equivalents	$	5,647	$	518
Restricted cash, current	400		1,000
Restricted cash included in other assets	40,672		40,730
Total cash, cash equivalents, and restricted cash shown in the Unaudited Condensed Consolidated Statements of Cash Flows	$	46,719	$	42,248

Schedule of earnings per share, basic and diluted reconciliation

The following table sets forth the reconciliations of net income (loss) and weighted average shares used for purposes of calculating the basic and diluted net income (loss) per common share for the periods indicated:


	Successor		Predecessor
In thousands	Three Months Ended March 31, 2021		Three Months Ended March 31, 2020
Numerator
Net income (loss) – basic	$	(69,642)	$	74,016
Effect of potentially dilutive securities
Interest on convertible senior notes including amortization of discount, net of tax	—		5,857
Net income (loss) – diluted	$	(69,642)	$	79,873

Denominator
Weighted average common shares outstanding – basic	50,319		494,259
Effect of potentially dilutive securities



Restricted stock and performance-based equity awards	—		1,078
Convertible senior notes(1)	—		90,853
Weighted average common shares outstanding – diluted	50,319		586,190

(1)In connection with the Company’s emergence from bankruptcy on September 18, 2020, all outstanding convertible senior notes were fully extinguished.

Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share

The following securities were excluded from the computation of diluted net income (loss) per share, as their effect would have been antidilutive:


	Successor	Predecessor
In thousands	Three Months Ended March 31, 2021	Three Months Ended March 31, 2020
Restricted stock units	466	—
Warrants	5,525	—
Stock appreciation rights	—	1,528
Nonvested time-based restricted stock and performance-based equity awards	—	14,007